Biden Administration COVID-19 adviser Anthony Fauci defends President Joe Biden’s decision to announce that vaccine booster shots will be available to most Americans by September 20, despite no indication that key regulators Will approve them in time.
During several Sunday morning news shows, Fauci urged fully vaccinated Americans not to get a booster shot, or a third dose of Pfizer or Moderna Vaccine, unless they were eligible. It came after the Food and Drug Administration’s (FDA) Vaccine Advisory Panel voted to recommend against providing Pfizer boosters to the general public, but in a setback to the White House’s booster plan, those 65 and older Shots recommended for Americans.
Fauci, who heads the National Institute of Allergy and Infectious Diseases since 1984, told “Meet the Press” that Biden’s plan had always relied on authorization by the FDA.
“I think people are not understanding the difference between planning for something and actually what element of it, what proportion of it, you’re actually going to roll out,” he said. “And that’s exactly what happened.”
Fauci also said that Americans who have been vaccinated and are waiting for a third shot need to be patient. Meanwhile, data from Johnson & Johnson and Moderna Vaccines is still needed.
“We’re working on that right now to get the data to the FDA so they can examine it and make a determination about boosters for those people,” he said. “They are not being left behind in any way.”
It is unclear when a final FDA decision on booster doses for people 65 and older may come, while the Centers for Disease Control and Prevention (CDC) scheduled a meeting next week to distribute the boosters across the United States. is of.
Echoing his call for patience during a CNN interview, Fauci on Sunday responded to a question about Americans getting booster shots without authorization, saying they “shouldn’t do that” and “follow the recommendation.” should” which was assigned by the FDA advisory panel. .
“We recommend that people wait until you fall into this category when it is recommended,” he said, adding that there is “always a theoretical risk” because the relevant studies on Pfizer vaccines are not yet has been done.
On September 17, the advisory panel voted 16-3 against the recommendation of a Pfizer booster for people under the age of 65. Some board members said they are concerned about a possible link between boosters and myocarditis, a type of heart inflammation.
Dr. James Hildreth, a polling member of the FDA expert panel, said that he “[has] serious concern of myocarditis in young people,” while others expressed concern about the data presented by Pfizer to the agency. Pfizer argued that over several months, its vaccine efficacy was reduced and thus additional dosage was required.
The Epoch Times has contacted the FDA for comment.
This News Originally From – The Epoch Times